Novel Therapeutic Strategy for Stroke in Rats by Bone Marrow Stromal Cells and ex vivo HGF Gene Transfer with HSV-1 Vector
…, WD Liu, T Kuroiwa, SI Miyatake - Journal of Cerebral …, 2006 - journals.sagepub.com
Occlusive cerebrovascular disease leads to brain ischemia that causes neurological deficits.
Here we introduce a new strategy combining mesenchymal stromal cells (MSCs) and ex …
Here we introduce a new strategy combining mesenchymal stromal cells (MSCs) and ex …
Boron neutron capture therapy for malignant brain tumors
SI Miyatake, S Kawabata, R Hiramatsu… - Neurologia medico …, 2016 - jstage.jst.go.jp
Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the
nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a …
nuclear capture and fission reactions that occur when non-radioactive boron-10, which is a …
Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain
SI MIyatake, N NoNoguchI, M FuruSe… - Neurologia medico …, 2015 - jstage.jst.go.jp
New radiation modalities have made it possible to prolong the survival of individuals with
malignant brain tumors, but symptomatic radiation necrosis becomes a serious problem that …
malignant brain tumors, but symptomatic radiation necrosis becomes a serious problem that …
The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles
N Nonoguchi, SI Miyatake, M Fukumoto… - Journal of neuro …, 2011 - Springer
The cell type and localization of vascular endothelial growth factor (VEGF)-producing cells
in human radiation necrosis (RN) are investigated from a histopathological and …
in human radiation necrosis (RN) are investigated from a histopathological and …
Survival benefit of boron neutron capture therapy for recurrent malignant gliomas
SI Miyatake, S Kawabata, K Yokoyama… - Journal of neuro …, 2009 - Springer
We have applied boron neutron capture therapy (BNCT) to malignant brain tumors. Here we
evaluated the survival benefit of BNCT for recurrent malignant glioma (MG). Since 2002, we …
evaluated the survival benefit of BNCT for recurrent malignant glioma (MG). Since 2002, we …
Boron neutron capture therapy for newly diagnosed glioblastoma
S Kawabata, SI Miyatake, T Kuroiwa… - Journal of radiation …, 2009 - ieeexplore.ieee.org
We evaluate the clinical results of a form of tumor selective particle radiation known as
boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma (NDGB) patients, …
boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma (NDGB) patients, …
Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation …
SI Miyatake, S Kawabata, Y Kajimoto, A Aoki… - Journal of …, 2005 - thejns.org
Object. To improve the effectiveness of boron neutron capture therapy (BNCT) for malignant
gliomas, the authors used epithermal rather than thermal neutrons for deep penetration and …
gliomas, the authors used epithermal rather than thermal neutrons for deep penetration and …
Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study
…, T Kato, H Goto, Y Narita, SI Miyatake - Neuro-oncology …, 2021 - academic.oup.com
Background Boron neutron capture therapy (BNCT) utilizes tumor-selective particle radiation.
This study aimed to assess the safety and efficacy of accelerator-based BNCT (AB-BNCT) …
This study aimed to assess the safety and efficacy of accelerator-based BNCT (AB-BNCT) …
Survivin expression is a prognostic marker in pancreatic cancer patients
…, T Mori, D Ito, K Fujimoto, M Wada, SI Miyatake… - Surgery, 2004 - Elsevier
BACKGROUND: In this study, we assessed survivin expression in pancreatic cancer specimens
from patients who underwent either pancreatic resection alone or pancreatic resection …
from patients who underwent either pancreatic resection alone or pancreatic resection …
Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence: case report
Y Kajimoto, T Kuroiwa, SI Miyatake, T Ichioka… - Journal of …, 2007 - thejns.org
✓It has been established that fluorescence-guided resection using 5-aminolevulinic acid (5-ALA)
is useful in glioma surgery. The authors report on a 65-year-old woman who had a …
is useful in glioma surgery. The authors report on a 65-year-old woman who had a …